Comparative Effects of Paraffin Bath Therapy and ESWT in Patients With De Quervain Tenosynovitis

Not Applicable

Completed

• Conditions: De Quervain Disease

• Registration Number: NCT05423353
• Lead Sponsor: Yuzuncu Yıl University

Brief Summary

There is no study in the literature comparing both paraffin bath therapy and Extracorporeal Shock Wave Therapy (ESWT) in the treatment of patients with De Quervain Tenosynovitis. The aim of this study is performing this comparison.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-06-14
• Study First Submitted QC: 2022-06-14
• Study First Posted: 2022-06-21
• Study Start: 2022-07-25
• Primary Completion: 2022-09-05
• Study Completion: 2022-10-19
• Status Verified: 2022-11
• Last Update Submitted: 2022-11-28
• Last Update Posted: 2022-11-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

• Being 18 years or older
• Meeting De Quervain diagnostic criteria
• Not having applied any physical therapy modality to the hand-wrist in the last 1 month
• Not using pain medication in the last 1 month,
• Not using local anesthetics or steroid injections on the hand-wrist in the last 3 months
• Have received written consent to participate in the study, and have come to the last control at the 6th week.

Exclusion Criteria

• Neurological diseases (especially neuropathies),
• Malignancy,
• Rheumatological diseases
• Pregnancy
• History of hand/wrist fracture or surgery
• Hand/wrist trauma in the last 1 month
• Coagulation disorder diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Duruöz Hand Index (DHI)	6 weeks after baseline (one month after the end of treatment)	Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies. It consists of 18 items that evaluate hand and wrist activities. The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90.
Visual Analogue Scale (VAS)	6 weeks after baseline (one month after the end of treatment)	patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse

Trial Locations

Locations (1)

Yuzuncu Yil University; 🇹🇷 Van, Turkey